Humacyte: Peers

The FY2025 (Dec) proxy of Humacyte names 17 peer companies for pay. Among Humacyte and these peers, CEO pay was 7th highest of 12 and total shareholder return was 9th highest of 12.

7th highest of 12in Humacyte and its pay peers, FY2025 (Dec) by CEO pay:

$2.4M$33.3M

9th highest of 12in Humacyte and its pay peers, FY2025 (Dec) by total shareholder return:

$18$487

Pay peer group, FY2025 (Dec) proxy

Scholar Rock Holding
Cogent Biosciences
Arcutis Biotherapeutics
Vera Therapeutics
Tarsus Pharmaceuticals
Anaptysbio
Kura Oncology
Relay Therapeutics
Regenxbio
Rocket Pharmaceuticals
Editas Medicine
CVRx, Inc.Not disclosedNot disclosed
Day One Biopharma, Inc.Not disclosedNot disclosed
MaxcyteNot disclosedNot disclosed
OmerosNot disclosedNot disclosed
PureTech Health plcNot disclosedNot disclosed
Syndax PharmaceuticalsNot disclosedNot disclosed
17 companies

Changes by year

No proxy on file names a change to the peer group.

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.